There is currently no treatment for this disease. The extremely hypopigmented skin that is characteristic in OCA1 particularly leads to risk of skin damage and non-melanotic skin cancers due to increased sensitivity to UV rays. In OCA1B, because there is some presence of melanin, it grows with age and pigmentation can increase; the same cannot be said for OCA1A. Individuals affected by OCA1A should be attentive to the amount of sun exposure they experience and wear proper protection such as clothing that covers the skin. Additionally, individuals may need corrective visual aids for their visual acuity of 1/10 or less with intense photophobia. Visual aids can both improve vision or protect eyes from bright lights. These visual aids can be adjusted for based on individual needs. Individuals should receive annual skin evaluation to access for damage or skin cancers that can be induced from sun exposure. In some situations, therapy or surgery can correct crossed eyes (strabismus) or rapid eye movements (nystagmus).
Oculocutaneous albinism type I
Ocular albinism type 1
Ocular albinism
Retinoschisis
Lafora disease
Yemenite deaf-blind hypopigmentation syndrome
Danon disease
Hypohidrotic ectodermal dysplasia